From: Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic
Variable | COVID-19 Positive | COVID-19 Negative | p-value |
---|---|---|---|
Number of Patients | 43 | 668 | Â |
Overall previous diseases | 27 (62.79%) | 156 (23.35%) | <  0.0001 |
Stroke | 1 (2.33%) | 2 (0.3%) | 0.1709 |
Myocardial Infarction | 2 (4.65%) | 9 (1.35%) | 0.1390 |
Chronic Heart Disease | 1 (2.33%) | 23 (3.4%) | 1.0000 |
Inflammatory Bowel Disease | 0 | 8 (1.2%) | 1.0000 |
Rheumatological Disorder | 1 (2.33%) | 14 (2.10%) | 0.6115 |
Transplantation | 0 | 3 (0.45%) | 1.0000 |
Kidney Disease | 4 (9.30%) | 3 (0.45%) | 0.0004 |
Dialysis | 0 | 0 | n.a. |
Autoimmune Liver Disease | 0 | 1 (0.15%) | 1.0000 |
Liver Cirrhosis | 1 (2.33%) | 2 (0.30%) | 0.1709 |
Lung Disease | 5 (11.63%) | 72 (10.78%) | 0.8010 |
Lupus | 0 | 2 (0.30%) | 1.0000 |
Hypertension | 4 (9.30%) | 34 (5.1%) | 0.2787 |
Endocrine disorder | 2 (4.65%) | 28 (4.2%) | 0.7017 |
Diabetes | 1 (2.33%) | 21 (3.1%) | 1.0000 |
Allergic disorders | 1 (2.33%) | 33 (4.9%) | 0.7146 |
Other | 4 (9.30%) | 69 (10.3%) | 1.0000 |